ABM508 is a recombinant fusion protein consisting of the N-terminal 485 amino acids of diphtheria toxin joined to a-melanocyte-stimulating hormone. When expressed in Escherichia coli under the control of the tox promoter and signal sequence, ABM508 is severely degraded. When overexpressed from a thermoinducible lambda PR promoter fusion, ABM508 is largely insoluble. We compared the expression of ABM508 (501 amino acids) to a full-length mutant form of the toxin (CRM197; 535 amino acids) and found that CRM197 showed minimal proteolysis. Thus, the removal of the C-terminal 50 amino acids of the toxin destabilizes the protein, making it a target for proteases. Proteolysis of ABM508 could be reduced by removal of the tox signal sequence (thereby directing the protein to the cytoplasm) and growth in Ion and htpR mutant strains of E. coli. We also showed that the solubility of tox gene products expressed in E. coli was directly related to the growth temperature of the culture. Thus, a fragment A fusion protein (223 amino acids), ABM508, and CRM197 were found in soluble extracts when expressed at 30°C but could not be released by the same procedures after growth at 42°C. On the basis of these observations, we fused the coding sequences for mature ABM508 to the trc promoter (inducible at 30°C by isopropyl-(B-D-thiogalactoside) and expressed this construct in a lon htpR strain of E. coli. This plasmid made 10 mg of soluble tox protein per liter of culture (7.7% of the total cell protein) or 14 times more than our previous maximal level. Extracts from lon htpR cells harboring this plasmid had high levels of ADP-ribosyltransferase activity, and although proteolysis still occurred, the major tox product corresponded to full-length ABM508.
Diphtheria toxin (for a review, see reference 42) is a 535-amino-acid polypeptide (27, 32, 45) that is secreted in amounts as large as 500 mg/liter by toxinogenic strains of Corynebacterium diphtheriae grown under appropriate conditions (46) . The toxin can be resolved into two fragments by mild proteolysis and disulfide reduction (17, 21) . Fragment A (Fig. 1) , the N-terminal 193 amino acids, is an ADPribosylating enzyme which catalytically inactivates eucaryotic elongation factor 2 (12, 26) . Fragment B, the C-terminal 342 amino acids, performs two functions: translocation of fragment A across eucaryotic cell membranes (16, 34) and binding the toxin to a surface receptor on sensitive cells (31) . The binding domain is believed to be localized to the C terminus of fragment B (55) .
Because diphtheria toxin can kill animals and humans at a dose as low as 100 ng/kg (20) , there has been great interest in targeting the toxicity of the protein to particular types of cells. This has been attempted at the level of protein chemistry by coupling whole toxin or toxin fragments to antibodies (23, 52) , hormones (3), or lectins (22) . More recently, attention has turned to making genetically engineered targeted toxins. This approach has the advantages that the junction between the toxin and the targeting ligand can be specified and that larger fragments of the toxin than crossreacting material 45 (CRM45; a 386-amino-acid nonsense mutant of the toxin [19, 55] often used for making chemically linked hybrid toxins) can be engineered.
We have reported the genetic construction and expression in Escherichia coli of two diphtheria toxin-hormone fusion proteins which contain the N-terminal 485 amino acids of the toxin fused to either a-melanocyte-stimulating hormone or MATERIALS AND METHODS Strains. The bacterial strains used in this study are listed in Table 1 . SY327 is a recA strain and was used for DNA transformations and plasmid maintenance. JM105 and RB791 contain the lacIq mutation and were used for cloning genes under the control of the trc promoter. The SG strains are protease deficient and were used for expression studies.
Plasmids. The plasmids used in this study are listed in Table 2 . The parent vector for pDT201 is pUC8 (56) , for pABM508 and pP197 it is pEMBL8 (14) , for pDT1201, pABM1508, and pABM4508 it is pEMBLex3 (15) , and for pABM6508 it is pKK233-2 (1; available from Pharmacia, Inc., Piscataway, N.J.).
Construction of recombinant plasmids. Plasmid DNA was cut and modified with enzymes purchased from New England BioLabs, Inc., Beverly, Mass., used as recommended by the manufacturer. Plasmids were introduced into E. coli cedure, and purified by CsCl density gradient centrifugation (36) . The 10-base oligonucleotide used to construct pABM6508 was made with a solid-phase, automated DNA synthesizer (model 380A; Applied Biosystems, Foster City, Calif.), using phosphoramidite nucleotides and controlledpore glass columns (Applied Biosystems). Before use it was purified by polyacrylamide gel electrophoresis as described previously (39) . Cross-reacting material 197 (CRM197) is a missense mutant of diphtheria toxin that is devoid of ADP-ribosyltransferase (ADPRT) activity and is thus nontoxic (55) . Its gene carries a single base substitution, resulting in the incorporation of glutamic acid instead of glycine at residue 52 (19 The double digestion deleted a 56-base-pair restriction fragment which encodes amino acids -26 to -7 of the pABM1508 signal sequence. The sticky ends were blunted with tnung bean nuclease and joined with T4 DNA ligase to produce the pABM4508 in-frame fusion. This plasmnid codes for the formylmethionine (fMet) of the PR promoter and the cro gene fused to amino acid -6 of the tox signal sequence (Fig. 1) . The deletion inactivates the tox signal sequence and concomitantly adds six amino acids (assuming removal of the fMet) to the amino terminus of the mature toxin. pABM6508 carries the ABM508 gene under the control of the trc promoter; it lacks the entire tox signal sequence, with fMet fused to Gly1 of the mature toxin (Fig. 1) 16 ,000 x g for 10 min at 4°C. The resulting supernatant was designated the soluble fraction and was mixed with an equal volume of 2x reducing loading buffer; the pellet, designated the insoluble fraction, was resuspended in 1 volume of TEP and dissolved by the addition of an equal volume of 2 x reducing loading buffer. Proteins were separated on 10% SDS-polyacrylamide gels, transferred to nitrocellulose, and stained with horse anti-diphtheria toxin antibodies (Connaught Laboratories, Swiftwater, Pa.) as previously described (6) . With these antibodies, extracts of E. coli carrying only the parent vectors for our tox plasrnids showed no appreciable immunoreactivity on Western blots. The molecular weight standards for the blots contained 195'196'197'198'199 RIA. Portions (100 ml) of cultures grown as described above were harvested by centrifugation and suspended in 10 ml of 30 mM Tris hydrochloride-5 mM EDTA (pH 8.0). The cells were lysed by sonication as described above, and after centrifugation (10 min at 7,500 x g at 4°C), the soluble fraction was stored in aliquots at -70°C. To control for varying degrees of proteolytic degradation, we used a modification of the diphtheria toxin cross-reacting material RIA developed by K. Parker and K. Campbell (Seragen, Inc., Hopkinton, Mass.) by substituting fragment A-specific polyclonal antibodies for the whole antitoxin serum. With this change, fragment A and nicked diphtheria toxin are recognized in the assay with equal sensitivity (50% inhibitory concentration, 5 x 10-9 M). Because intact CRM45 is used as the tracer, intact CRM45 is recognized about three times more avidly (50% inhibitory concentration, 1.75 x 10-9 M), with a lower limit of detection for intact CRM45 of 0.75 x 10-9 M. In contrast, the same assay using unfractionated antitoxin serum is 10 times more sensitive for nicked whole toxin and intact CRM45 than for fragment A. Purified anti-fragment A antibodies were prepared by passing hyperimmune horse antitoxin serum (Sclavo) over a fragment A affinity column. The purified antibody preparation, which fails to recognize fragment B on Western blots, had an A280 of 0.212 and was diluted 1:1,000 for use in the RIA.
For the assay, 75 ,ul of sample diluted in assay buffer (10 mM sodium phosphate [pH 7.2], 0.9% NaCl, 0.1% bovine serum albumin) was mixed with 75 pLl of '25I-labeled CRM45 (3 x 105 cpm/ml) in assay buffer and 75 ,ul of purified horse anti-fragment A (1:1,000) containing horse immunoglobulin G (0.1 mg/ml; Cooper Biomedical, West Chester, Pa.) in assay buffer. After a 2-h incubation at 37°C, the antibodies were precipitated by the addition of 750 p.1 of goat anti-horse immunoglobulin G (0.3 mg of specific antibody per ml; Pel-Freez Biologicals, Rogers, Ark.) in 2.5% polyethylene glycol 6000-8000 (Sigma Chemical Co., St. Louis, Mo.-10 mM sodium phosphate (pH 7.2)-0.9% NaCl. After centrifugation at 16 ,000 x g for 5 min, the supernatants were aspirated off and the radioactivity in the pellets was counted on a Beckman Gamma 5500 instrument (Beckman Instruments, Inc., Fullerton, Calif.). Under these conditions nonspecific binding is typically 10 to 20% of total binding. Extracts from cells containing the parent vectors for our constructs produced no detectable fragment A immunoreactivity by this assay. Purified intact CRM45, prepared as described previously (43, 44) , was used as the standard.
CRM45 and 125I-labeled CRM45 were kindly provided by K.
Parker and K. Campbell (Seragen).
ADPRT assay and protein determination. The samples assayed by RIA were also tested for relative ADPRT activity by a method previously described (39) . Protein extracts from E. coli carrying the parent vectors for our tox plasmids were devoid of ADPRT activity. Measurements of total protein in the sonicated samples were made by the method of Bradford (7) and used in conjunction with the RIA determinations to calculate specific activity.
RESULTS
Immunoblot analysis of our previous efforts to express periplasm-directed ABM508 from either the tox promoter (pABM508) or the lambda PR promoter (pABM1508) showed many protein bands migrating between fragment A and full-length ABM508 (6, 39) . We attributed this to proteolytic degradation rather than incomplete transcription or translation because fragment A (a common proteolytic product of whole toxin) was a major product in our extracts. We also found that the recombinant protein was largely insoluble, since the spheroplast fraction after lysozyme-EDTA treatment of the harvested bacteria or the membrane fraction after French press lysis contained most of the immunoreactive ABM508 protein. On the basis of these observations, we began a series of experiments to identify variables that contributed to the proteolysis and insolubility.
Effect of fragment length on proteolysis. In a previous study with periplasm-directed proteins expressed from the lambda PR promoter (the 1000 series; 6), we found that a fragment A fusion protein (pDT1201, 223 amino acids) was expressed at a high yield and was not degraded. In contrast, longer fusion proteins which included portions of fragment B (pABM1313, 306 amino acids; pABM1402, 398 amino acids; and pABM 1508, 501 amino acids) were heavily degraded and produced multiple faint bands on Western blots. It appeared that fragment A was stable to proteolysis within E. coli, but when incomplete portions of fragment B were added, the molecule became a target for proteolytic attack. Thus, we decided to test whether a full-length diphtheria toxin-related polypeptide would also be the target of proteolysis in E. coli.
For these experiments we used the gene for CRM197, an inactive missense mutant of diphtheria toxin that differs from the wild type by a single amino acid substitution (Fig. 1) .
Although CRM197 is known to be less stable than whole toxin (58), we found that when expressed from the tox promoter with an intact signal sequence, p,197 produced large amounts of full-length protein (535 amino acids) in a strain with a wild-type protease background (Fig. 3, 
FIG. 3. Westem blot analysis
showing the effect of fragment length and host strain on expression. The five constructs indicated above the panels were grown in four different strains of E. coli under the conditions shown and induced as described in the text. After centrifugation the bacterial pellets were resuspended in volumes adjusted to give equivalent optical densities, lysed with SDS, and subjected to gel electrophoresis under reducing conditions. The protein in each lane in the three left panels came from 0.3 ml of culture at an A550 of 1.0. To avoid overloading in the panels for pABM6508 and pP3197, the lysed extracts were diluted fourfold relative to those in the other panels. Lanes:
A, strain SG931 (wild-type protease activity); B, strain SG932 (lon); C, strain SG934 (htpR); D, strain SG936 (Ion htpR); E, diphtheria toxin standards (whole toxin, 58 kDa; fragment B, 37 kDa; and fragment A, 21 kDa).
believed to result from jamming of the secretion apparatus by abnormally folded hybrid proteins.
To test whether localization of ABM508 in the E. coli cytoplasm would relieve the overexpression lethality associated with pABM1508 and perhaps result in higher yields of full-length fusion protein, we deleted the coding sequences for 18 amino acids of the tox signal sequence to produce pABM4508, a PR-driven, cytoplasm-directed form of the hybrid toxin. We also wanted to examine the effect of cytoplasmic localization on proteolytic degradation of the fusion protein. Although the cytoplasm is reputed to have greater protease activity than the periplasm (50) , most genetically engineered proteins have been directed to the cytoplasm, and several cytoplasmic protease mutants of E. coli have been developed to deal with the degradation problems in this compartment.
Our results show that deletion of the tox signal sequence did indeed relieve the overexpression lethality that occurs upon temperature induction of the periplasm-directed pAB3M 1508 (see Fig. 7B and C) . Shortly after the jump to 42°C, the culture harboring pABM1508 (periplasm-directed) stopped growing, whereas the higher temperature actually enhanced the growth rate of bacteria carrying pABM4508 (cytoplasm directed). Despite the poor growth rate of the pABM1508 culture, it did produce some full-length hybrid toxin in a strain with wild-type protease activity (Fig. 3, panel  pABM1508 , lane A. However, the cytoplasm-directed construct, pABM4508, which permits growth to higher densities after temperature induction, failed to produce detectable levels of full-length hybrid toxin in the same strain (Fig. 3,  panel pABM4508, lane A) . This observation is consistent with the reported higher levels of protease activity in the E. coli cytoplasm.
Effect of host strain on proteolysis. Next we examined the effect of lon and htpR mutant strains on the production of hybrid toxin. The E. coli lon gene codes for protease La, a 376-kDa, ATP-dependent, cytoplasmic protease that is one of the E. coli heat shock proteins (25) . The La protease has specificity for unfolded, abnormal proteins, and lon mutants have been shown to have a reduced ability to degrade such proteins. htpR is a heat shock regulatory gene which codes for &2, an alternate sigma factor for RNA polymerase (29) . cr3 iS made in increased amounts after exposure of cells to temperatures greater than 37°C, and it is believed to redirect RNA polymerase to the 17 or more heat shock genes in E. coli and increase their transcription (40) . Because several heat shock genes are known to encode proteases (e.g., the Ion gene) or protein processing enzymes (4), htpR mutants have reduced proteolytic activity, and the reduction is detectable even at 30°C (24) . htpR is an essential gene; the amber mutant we used is suppressed at low temperature by a supC(Ts) allele.
Using Western blots, we assessed the levels of degradation of the ABM508 protein in four E. coli strains that are isogenic except at their Ion and htpR loci. The proteasedeficient strains did little to improve the expression of the periplasm-directed constructs, pABM508 (p.OX driven) and pABM1508 (PR driven) (Fig. 3) . Moreover, the mutants did little to further stabilize the pP197 gene product (P,OX driven and periplasmic), which showed little degradation in the first place. The mutants had more noticeable effects on the cytoplasm-directed pABM4508 construct (PR driven). Both the lon strain (Fig. 3, panel pABM4508, lane B) and the htpR strain (lane C) showed roughly equivalent accumulation of the full-length species. The effect seems to be additive, sirpce the lon htpR double mutant (lane D) made even more full-length hybrid toxin.
These results show that directing ABM508 to the cytoplasm by deleting the tox signal sequence (as in pABM4508) leads to complete proteolysis in a protease-proficient strain. However, expression in lon and htpR mutants protected the cytoplasmic hybrid toxin and allowed the full-length species to accumulate. On the basis of this observation and the fact that bacteria expressing the cytoplasm-directed hybrid toxin did not display overexpression lethality and could thus be grown to high density during induction, we chose to pursue cytoplasmic accumulation in subsequent constructions.
Effect of temperature on proteolysis. High temperature is known to induce protease activity in E. coli (24) , and the htpR gene serves as a high-temperature positive regulatory element for at least part of this inducible activity. To determine whether our hybrid toxin is a substrate for this temperature-inducible activity, we grew some of our constructs in a lon host (SG932) at three different temperatures. Growth at 30°C allowed for the greatest accumulation of full-length fusion protein with both pABM508 (piox driven, periplasmic) and pP197 (ptox driven, periplasmic) (Fig. 4) . In these constructs degradation appears to increase with increasing temperature, suggesting that there may be a temperature-inducible protease activity which acts on them either in the periplasm or while they are in transit to the periplasm. It is noteworthy that cytoplasmic fusion protein expressed from pABM6508 (described below) did not show increased degradation at higher growth temperatures and thus does not seem susceptible to the degradation acting on pABM508 and pP197.
Effect of temperature on solubiity. Attempts to purify full-length hybrid toxin from SG936 carrying pABM4508 (PR driven, cytoplasmic) were unsuccessful because 90% of the immunoreactive protein remained associated with the cellular debris pellet after sonication or French press lysis and centrifugation. At first we believed this resulted from the cytoplasmic accumulation of this protein. However, we observed the same results with sonic extracts or lysozyme-EDTA-treated cells carrying pABM1508 (PR driven, periplasmic). This observation was a surprise since we (35) and others (54) had shown that fragment A alone is expressed and secreted to the periplasmic space in a soluble form.
Thinking that this insolubility resulted from the presence of much of fragment B in ABM508, we compared the solubilities of fragment A (pDT201) and CRM197 (pP197) expressed under the same conditions as the hybrid toxin encoded by pABM1508 and pABM4508. We found that neither the host strain nor the length of the tox fragment influenced the solubility of the expressed proteins but that incubation temperature did. Both our fragment A fusion protein (24.5 kDa) and CRM197 (58 kDa) were not completely released into the soluble phase when expressed at 42°C but were almost entirely soluble when expressed at 30°C (Fig. 5) . Because both of our PR-driven constructs could only be expressed by temperature induction at 42°C, this finding explained our inability to isolate soluble tox protein by using the PR system. Analysis of pABM6508. Our findings described above made it clear that we needed a different high-expression promoter that could be induced at low temperature. We believed that the proteolysis problem could be overcome with the Ion htpR double-mutant strain and that we could take full advantage of these mutations by localizing the new hybrid toxin to the cytoplasm. To test this hypothesis, we assembled pABM6508 (Fig. 2) , in which the ABM508 gene is driven by the trc promoter, a variant of the tac promoter (13) in which the spacing between the -35 and -10 consensus sequences has been changed from 18 to 17 base pairs (10) . The tac and trc promoters have been used by others to express recombinant proteins in E. coli at levels as high as 25% of cell protein (2, 49) . In addition to having a strong E. coli promoter, pABM6508 also carries two rho-independent transcriptional terminators from the rrnB operon (9) at the end of the ABM508 gene.
When introduced into the lon htpR strain, pABM6508 could be induced with IPTG to express much higher levels of (Fig. 6 ). pABM6508 showed a proteolytic profile similar to that of pABM4508 (Fig. 3) , with the protease-deficient host strains showing greater accumulation of full-length product than did the protease-proficient strain. Surprisingly, growth at high temperature did not reduce the accumulation of the pABM6508 gene product as significantly as it did for the periplasmic constructs, pABM508 and p,197 (Fig. 4) . High temperature did, however, reduce the solubility of the hybrid toxin expressed from pABM6508 (Fig. 5) . We estimate that after growth at 30°C about 50% of the full-length protein can be released into the soluble phase, whereas most of the full-length material is insoluble after growth at 42°C. Levels of accumulation. To determine how much hybrid toxin is produced by our various hybrid toxin genes, we grew cultures of SG936 carrying the different ABM508 vectors and harvested cells at four different times during growth (Fig. 7) . Soluble extracts were assayed for total protein, ADPRT activity, and fragment A immunoreactivity. We deliberately measured fragment A immunoreactivity and not whole-toxin immunoreactivity so that C-terminal degradation products that might be present in various proportions in the extracts would be recognized equally. The results are shown in Fig. 7 ; the maximal values from the graphs are listed in Table 2 .
As anticipated, pABM508 (Ptox driven, periplasmic) made hybrid toxin in a constitutive fashion, with the specific activity remaining constant during exponential growth and then dropping toward the beginning of the stationary phase (Fig. 7A) . Whereas fragment A immunoreactivity dropped at the end of the exponential phase, ADPRT activity continued to increase. This suggests that, like whole toxin, ABM508 requires nicking within the disulfide loop joining fragments A and B to be enzymatically active. In older cultures the hybrid toxin product is probably more nicked and thus more enzymatically active even though synthesis levels have decreased.
Whereas ADPRT activity and fragment A immunoreactivity were not detectable in pABM1508 and pABM4508 before induction, there was a rapid burst of synthesis by both constructs after the jump to 42°C (Fig. 7B and C) . As mentioned above, strain SG936 is temperature sensitive but nevertheless capable of several doublings when heated to 42°C during the mid-exponential phase. The presence of pABM1508, however, caused an overexpression lethality that was probably responsible for the precipitous drop in accumulation levels 90 min after induction. pABM1508 and pABM4508 made 0.7 and 0.2 mg of hybrid toxin per liter, respectively, as assessed by fragment A immunoreactivity, which is close to the maximal level made by pABM508 (0.4 mg/liter). This was unexpected because the tox promoter is considered a low-to-intermediate-strength E. coli promoter (33) , whereas PR is a very strong promoter for E. coli. We believe that the pR-driven constructs actually produce higher levels than these but that the protein goes undetected because of high-temperature insolubility.
At 3 h after induction, pABM6508 produced 10 mg of hybrid toxin per liter of culture or 7.7% of the total cell protein (Fig. 7D) ; this is 14 times higher than our previous maximal level of expression. Unlike results with the other three constructs, the specific activity curve continued to increase throughout the growth cycle, suggesting that even higher yields might be obtained by prolonged induction. Another factor that might improve the levels of production by this vector is the introduction of a lacIq superrepressor allele in strain SG936. This strain carries a chromosomal wild-type lacI repressor gene which cannot completely repress lac (or trc) transcription from multicopy plasmids. This was borne out by the fact that even before induction with IPTG, pABM6508 made 1.0 mg of hybrid toxin per liter or about 2.7% of the total cell protein. Although the plasmid is stably maintained without a lacIq allele, it may be possible to achieve more rapid growth to a higher preinduction density with this stronger repressor. Finally, it should be noted that about half of the hybrid toxin produced by pABM6508 at 30°C was insoluble; thus, the actual level of synthesis may be well above 10 mg/liter. A number of factors probably contributed to the high levels of expression seen in pABM6508; these include the strength of the trc promoter, the increased solubility gained by growth at 30°C, the absence of overexpression lethality resulting from deletion of the tox signal sequence, and the reduction in degradation provided by the lon htpR mutant host. Two additional factors may also have played a role in the 14-fold improvement in expression. First, all of our constructs except pABM6508 produce mRNA capable of forming a stem-loop structure with a free energy of -7.1 kcal (-29.7 kJ)/mol between the codons for Ser-4 and Asp+3 (Fig. 8) . Similar mRNA secondary structures around the site of translation initiation have been reported to decrease expression levels in other systems (11, 57) , and the removal of this potential stem-loop in pABM6508 may provide some 
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advantage. Second, pABM6508 contains two rho-independent transcription terminators after the ABM508 gene, whereas the other ABM508 constructs lack specific terminators. The presence of termination signals could stabilize the hybrid toxin message in pABM6508 and lead to increased expression (18) . DISCUSSION There has been considerable interest in expressing recombinant diphtheria toxin fragments in E. coli because of their potential use in making immunotoxins. Greenfield et al. (28) have successfully overexpressed fragment A to 7% of the total cell protein (by RIA) by deleting its signal sequence and fusing it to the lambda PL promoter. Like pABM1508 and pABM4508, this construct requires thermal induction at 42°C. An analogous construct containing fragment B sequences up to amino acid 383 also gives a high level of synthesis (5 to 10% of cell protein by SDS-polyacrylamide gel analysis), but its expression is not consistently high and it is not clear what proportion of the material is soluble. To avoid proteolysis and insolubility, Zettlmeissl et al. (60) have fused the gene for the N-terminal 429 amino acids of CRM228 (a full-length, inactive cross-reacting material of diphtheria toxin which contains four amino acid substitutions [32] ) to the gene for P-galactosidase. When expressed from the lambda PR promoter by heat induction, this fusion protein is soluble and can be purified in one step with affinity columns for ,B-galactosidase. We have successfully purified a diphtheria toxin-related interleukin-2 hybrid protein (ABI 508) to near homogeneity from the periplasmic space of E. coli (Williams et al., submitted). Although this hybrid protein is expressed at a low yield from the tox promoter, it is soluble when the cells are grown at low temperature and can be purified away from the tox degradation products by affinity chromatography with anti-interleukin-2 antibodies.
ABM508 is a hybrid toxin analogous to ABI508; it is comprised of the first 485 amino acids of diphtheria toxin translationally fused to the 13-amino-acid peptide hormone, a-melanocyte-stimulating hormone. While it has been shown to have cytotoxicity for human melanoma cells in vitro, further studies of this toxicity have been hampered by a combination of low levels of synthesis, insolubility, and proteolytic breakdown to undesirable cross-reacting materials.
In this study we systematically considered variables that contribute to this low yield. We showed that fragments of diphtheria toxin intermediate in length between fragment A (193 amino acids) and whole toxin (535 amino acids) are substrates for proteolytic activity in E. coli, whereas fragment A alone and CRM197 expressed in E. coli are not. Indeed, our data show that the removal of as little as 50 amino acids from the C terminus of diphtheria toxin prevents proper folding upon expression in E. coli and leads to an unstable structure with increased proteolytic sensitivity.
Pakula et al. (41) have studied a large number of missense mutations in the lambda Cro repressor, for which the threedimensional structure is known. One class of mutations disrupts the structure of the protein and causes severe proteolytic degradation in E. coli that can be partially prevented in lon and htpR mutant strains. Although highly sensitive to E. coli proteases, many of these structural mutants have specific activities close to that of wild-type Cro. Thus, while the protease sensitivity of hybrid toxin ABM508 probably reflects altered folding of the polypeptide, this does not necessarily imply that the activity of fragment B (namely, membrane translocation) has been compromised.
Our results show that the htpR and lon mutations stabilize cytoplasmic versions of the hybrid toxin. This is consistent with the role of the htpR gene product as an activator of different proteases and the role of the lon gene in coding for a single cytoplasmic protease. ABM508 is thus a substrate for protease La and for other proteases regulated by htpR; however, even in these mutants there are other protease activities which appear to cleave the ABM508 protein at specific sites, giving rise to characteristic breakdown products.
When the ABM508 protein was directed to the cytoplasm (pABM4508) in a protease-proficient host, degradation was more severe than for the periplasmic version under the control of the same promoter (pABM1508). This agrees with the work of Talmadge and Gilbert (51), who found that penicillinase is 10 times longer lived in the periplasm than in the cytoplasm. However, the lon and htpR mutants relieved much of this proteolysis, allowing the cytoplasmic hybrid toxin to accumulate. Moreover, unlike the periplasmdirected construct (pABM1508), the cytoplasm-directed pABM4508 did not cause overexpression lethality upon induction and thus could be grown to high density during induction. These factors led us to choose cytoplasmic accumulation for our p,rc-driven hybrid toxin gene in pABM6508. An important finding in this study was that tox proteins were largely insoluble when expressed at a high temperature (42°C). This phenomenon was independent of fragment length, since fragment A, ABM508, and CRM197 expressed in E. coli were each insoluble when expressed at 42°C. The insolubility was also independent of host strain and occurred with both the cytoplasm-directed and periplasm-directed proteins. Since the optimal temperature for toxin production from C. diphtheriae is 34°C, even though the organism is capable of growth at higher temperatures (48) , the temperature-related insolubility probably reflected a true conformational alteration of diphtheria toxin and its fragments at 42°C and was not an artifact of expression in E. coli.
Zhao and London (61) have shown that at 45 to 50°C diphtheria toxin undergoes thermal denaturation to a conformation that is more hydrophobic than that at low temperature and resernbles the low pH conformation of the toxin. Within endosomes, fragment B of the toxin penetrates the eucaryotic cell membrane when the pH drops below 5.5 (37, 47) . This process is believed to involve an acid-sensitive conformational change which exposes hydrophobic domains within fragment B that are normally buried. Expression of toxin-related proteins at high temperature might lead to a similar denaturation phenomenon which exposes these hydrophobic domains and causes aggregation. However, the hydrophobic character of fragment B at high temperature or low pH cannot completely account for our findings because fragment A alone expressed in E. coli showed high-temperature insolubility. Overexpression insolubility in E. coli has been observed with other recombinant proteins and seems to be related to abnormal polypeptide folding (25) .
Using the results from the expression experiments, we designed and constructed pABM6508, a p,rc-driven cytoplasmic version of the hybrid toxin. After induction with IPTG, our lon htpR strain made up to 10 mg of soluble hybrid toxin per liter (7.7% of cell protein by RIA), or 14 times more than our previous maximal level. We believe that low-tempera-FIG. 7 . Levels of accumulation of four ABM508 constructs. Strain SG936 (lon htpR) harboring the plasmids shown was grown to an A550 of 0.5 at 30°C before induction by heat shock (pABM1508 and pABM4508) or addition of IPTG to 1 mM (pABM6508). No alterations were made in the culture conditions for pABM508. Samples were harvested just before induction and at 30, 90 , and 180 min after induction. Soluble extracts were prepared for each time point and assayed for fragment A immunoreactivity, relative ADPRT activity, and total protein. ture growth, inducible, cytoplasmic expression, a strong E. coli promoter, and the use a protease-deficient host strain all contributed significantly to this improvement in expression.
The high levels of expression of soluble hybrid toxin from pABM6508 should make it possible to isolate the full-length fusion protein at a high yield. The combined availability of a high-level expression system such as this and an efficient purification scheme, which we are working to develop, should allow for rapid construction and characterization of many targeted forms of diphtheria toxin in the near future.
